Price (delayed)
$521
Market cap
$56.25B
P/E Ratio
12.47
Dividend/share
$1.76
EPS
$41.77
Enterprise value
$55.86B
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Tarrytown, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities , it
Special dividends are included in TTM DPS and yield
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.